Metraipolis › archive › dc_706cb59d7b48

Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42239517
DOI
10.3389/fphar.2026.1758062
License (as archived)
solo-consultazione
Archived
2026-11-01T15:12:44.247Z
SHA-256 of the archived text
115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e
Stable URL of this page
https://metraipolis.com/documento/dc_706cb59d7b48

How to cite

Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517 — Europe PMC (en), https://europepmc.org/article/MED/42239517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_706cb59d7b48 (Metraipolis archive dc_706cb59d7b48, sha256 115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e)
BibTeX
@misc{dc706cb59d7b48,
  title = {Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42239517},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_706cb59d7b48; sha256 115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42239517. Agents can read the archived copy with the MCP tool read_document.